| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Fredrik Dalborg CEO | XSTO Exchange | - ISIN |
| SE Country | 2,251 Employees | - Last Dividend | 27 May 2020 Last Split | - IPO Date |
AddLife AB (publ) is a distinguished entity, nestled in the heart of Stockholm, Sweden, and has been in operation since 1906. The company, along with its subsidiaries, is deeply entrenched in the provision of a broad spectrum of products, consumables, and reagents, catering primarily to the healthcare sector. Its offerings extensively support research, colleges, and universities, in addition to serving the nuanced needs of the food and pharmaceutical industries. AddLife operates through two primary segments, Labtech and Medtech, each tailored to meet the distinctive demands of diagnostics, biomedical research, laboratory equipment, and medical device products across a wide range of medical and scientific disciplines. With a footprint that extends across Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, the rest of Europe, and international borders, AddLife stands as a pivotal link in the global healthcare and research supply chain.
This division is devoted to supplying an array of products, solutions, and services in diagnostics, biomedical research, and laboratory equipment. It not only furnishes plastic consumables, cell biology essentials, and reagents but also offers various lab and other instruments. Each product under this segment is designed to enhance the efficiency and efficacy of laboratory operations across healthcare and research settings.
Under the Medtech umbrella, AddLife provides an extensive selection of medical device products tailored for a myriad of applications, including surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, and more. This segment also caters to specialized fields such as ear, nose, and throat (ENT), ostomies, and home healthcare, alongside deploying assistive technology for senior citizens and disabled children. The objective is to improve patient care and facilitate a better quality of life through innovative medical technologies and products.